On January 24, 2014 the European Commission announced their marketing authorization to both AstraZeneca and Bristol-Myers Squibb for Xigduo. As a powerful medication for type 2 diabetes, Xigduo is a combination of Dapagliflozin and Metformin Hydrochloride, and available in two dosages: 5mg/850mg and 5mg/1,000mg tablets, respectively. This dynamic duo of powerhouse anti-diabetic medications is designed[…]
Dapagliflozin and Metformin Hydrochloride Earn EU Approval as Xigduo
Anti-Diabetic, EU Approved 2014 Tags: DapagliflozinEuropean CommissionMetformin Hydrochloride Jan 27, 2014
Alogliptin Shines in Three Recent FDA Approvals
Anti-Diabetic, Blood Product, Drug Research & Development API, Gliptin Tags: JanuviaMetformin Hydrochloridetype 2 Diabetes Feb 06, 2013
Alogliptin is a current newsmaker in the pharmaceutical industry. On January 25, 2013 Takeda announced that Alogliptin, CAS# 850649-62-6, was approved alongside Metformin HCl, CAS# 1115-70-4, in the novel type 2 diabetes medication Kazano. As an efficacious and highly selective DPP-4 inhibitor, Alogliptin, when combined in this single dose tablet with metformin HCI effectively aids[…]
Linagliptin and Metformin Hydrochloride Tag Team to Combat Type 2 Diabetes
Anti-Diabetic, Antibiotic, Blood Glucose Regulator, Drug Research & Development API, Gliptin Tags: LinagliptinMetformin Hydrochloridetype 2 Diabetes Aug 17, 2012
As a chronic disease which occurs when the body does not properly produce, or use the hormone insulin, type 2 diabetes has become a worldwide problem. Roughly 25.8 million Americans and an estimated 366 million people worldwide have diabetes, according to the CDC and 2011 data from the IDF. Type 2 diabetes accounts for 90-95[…]
Metformin Hydrochloride Studies
Anti-Diabetic, Blood Glucose Regulator, OTC and Compounding Product, TEVA API Tags: anti-diabeticLDLMetformin HydrochlorideObesitytype 2 Diabetes Dec 08, 2010
Metformin Hydrochloride is one of the most recommended medicines for the treatment of patients suffering from biguanide or type 2 Diabetes. According to recent studies, Metformin Hydrochloride reduces the LDL and triglyceride levels in the blood and hence it is one of the best medicines for diabetic patients who are also suffering with obesity. Studies[…]
